Preventing the Gaps in Psychedelic Research from Becoming Practice Pitfalls: A Translational Research Agenda.
Psychedelic Medicine December 13, 2023 DOI: 10.1089/psymed.2023.0017 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Psychedelic-assisted therapy |
| Keywords | Mental health treatment Clinical standards Medical safety protocols Therapeutic regulation |
| Citations | 7 |
| Key findings | The article identifies key research questions needed to understand how to safely and effectively use psychedelic-assisted therapy in clinical populations. |
Abstract
The reemergence of psychedelic medicines as clinical treatments has generated considerable interest in both professional and popular arenas. Although evidence is promising for psychedelic-assisted therapy (PAT), there is much that is not yet known and needs to be researched so as to understand how to safely and effectively utilize PAT in clinical populations and to most effectively deploy PAT to patients. In addition, non-clinical stakeholders introduce interests and agendas that may differ from those of clinicians. This article reviews the history of how psychedelics were initially outlawed and then introduces research questions that will help to fill these gaps in knowledge.
Comparable studies
Other narrative reviews on psychedelic-assisted therapy, most cited first.
Citations in the library
Cited by 7
- Psychedelics in Psychiatry, the Nursing Influence, and the Future of Psychedelic Therapies Journal of the American Psychiatric Nurses Association January 29, 2024
- Not a Standalone Treatment: Considerations for Psychedelic‐Assisted Therapy Brain and Behavior April 1, 2026
- “Skin contains land and birds”: Understanding inner healing intelligence through critical vitalism and Indigenous thought Journal of Psychedelic Studies July 28, 2025
- "I've learned that I'm open-minded to this possibility": A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smoke. Addiction Science & Clinical Practice July 21, 2025
- T-shaped expertise: rethinking interdisciplinarity in psychedelic research Psychedelics June 28, 2026
and 2 more in the library
Cites 33
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Trial of Psilocybin versus Escitalopram for Depression New England Journal of Medicine April 14, 2021
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. New England Journal of Medicine November 3, 2022
- MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine June 1, 2021
and 28 more in the library